Tranexamic Acid NDC 62559-265

NDC codes

FDA NDC Directory

Product NDC (as listed)62559-265Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62559-0265Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62559-265-30	62559026530	30 TABLET in 1 BOTTLE (62559-265-30)Marketed from Jul 1, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tranexamic Acid
Generic name (nonproprietary): tranexamic acid
Active ingredients: Tranexamic acid — 650 mg/1
Dosage form: Tablet
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203256
Marketing start: Jul 1, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Fibrinolysis (Physiologic effect)
Identifiers: Product ID 62559-265_edec7ff1-1b0a-414b-a719-e65376c7034bSPL ID edec7ff1-1b0a-414b-a719-e65376c7034bSPL set ID 82bc4879-bcf5-47c4-8636-a73c4e7d0de9RxCUI 883826UNII 6T84R30KC1UPC 0362559265300
Pharmacologic class: Antifibrinolytic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462559026530 followed by a unit qualifier and the quantity

Package 62559-0265-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 19, 2025.

Indications (excerpt from the label)

Tranexamic Acid Tablets are indicated for the treatment of cyclic heavy menstrual bleeding in females of reproductive potential [see Clinical Studies ( 14 )]. Tranexamic Acid Tablets are an antifibrinolytic indicated for the treatment of cyclic heavy menstrual bleeding in females of reproductive potential. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 203256

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203256
Product	Strength	Form · route	Labeler	Product NDC
Tranexamic Acid	Tranexamic acid 650 mg/1	TabletOral	American Health Packaging	60687-750
Tranexamic Acid	Tranexamic acid 650 mg/1	TabletOral	Bryant Ranch Prepack	71335-1981